Clinical tests begin on medication to correct Fragile X defect
Monday, November 2, 2009 - 13:49
in Health & Medicine
NIH-supported scientists at Seaside Therapeutics in Cambridge, Mass., are beginning a clinical trial of a potential medication designed to correct a central neurochemical defect underlying Fragile